experimental group:GM-CSF+PD-1 antibody

An open, single-arm, single-centre study of PD-1 monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the second-line treatment of driver-negative advanced non-small cell lung cancer in a phase II clinical study

Real-world observational study of PD-1/PD-L1 inhibitor combined with GM-CSF in the treatment of advanced solid tumors